16 Total results for product and free and sample content found
Pharma Intelligence Apps
07 Jan 2022
Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.
02 Dec 2021
Get exclusive insights into what senior decision makers from small to large biotech and pharma companies want from contract research organizations.
Scrip
19 Oct 2021
The 2021 Titans of Pharma provides snapshot of the industry’s top 15 leaders and the businesses they oversee, with vital statistics covering the compensation of CEOs and R&D heads, median employee pay, and company performance.
In Vivo
27 May 2021
Gain insights into managing unexpected events, effectively communicating change, executing crisis management plans, and more. Industry experts share their insights into innovative ways to integrate teams after M&A, manage D&I initiatives, and build strong leadership for a changing workforce.
Topic Leadership
Medtech Insight
29 Nov 2020
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
In Vivo
By William Looney 27 Nov 2020
Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.
Scrip
06 Jul 2020
Scrip’s eagerly awaited annual snapshot of pharma leadership in 2020 is here. The 2020 Titans of Pharma infographic features key information on the industry’s top leaders and the mega companies they oversee.
Topic Leadership Market Access
Scrip
06 Jul 2020
CEO pay at the top 15 pharma companies increased by 3.9% in 2019. But how did that match up to company performance? Read the article now available from Scrip and learn who were the big winners, and how their companies performed financially.
Scrip
By Nielsen Hobbs 03 Jun 2020
‘What we have to guard against is that when the streets quiet down … a lot of people are going to go back to their normal lives,’ Merck CEO Ken Frazier says in an interview with CNBC.
Topic Leadership
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: